Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.85 USD | +11.11% | +11.48% | +4.94% |
Financials (USD)
Sales 2024 * | 30.79M | Sales 2025 * | 11.82M | Capitalization | 84.11M |
---|---|---|---|---|---|
Net income 2024 * | -63M | Net income 2025 * | -84M | EV / Sales 2024 * | 2.73 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 7.11 x |
P/E ratio 2024 * |
-1.83
x | P/E ratio 2025 * |
-1.73
x | Employees | 165 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 78.46% |
Latest transcript on HOOKIPA Pharma Inc.
1 day | +11.11% | ||
1 week | +11.48% | ||
Current month | +19.38% | ||
1 month | +19.53% | ||
3 months | +18.35% | ||
6 months | +86.20% | ||
Current year | +4.94% |
Managers | Title | Age | Since |
---|---|---|---|
Jörn Aldag
CEO | Chief Executive Officer | 65 | 16-05-31 |
Reinhard Kandera
DFI | Director of Finance/CFO | 54 | 17-03-31 |
Klaus Orlinger
CTO | Chief Tech/Sci/R&D Officer | 46 | 12-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jörn Aldag
CEO | Chief Executive Officer | 65 | 16-05-31 |
Chairman | 63 | 17-09-30 | |
Reinhard Kandera
DFI | Director of Finance/CFO | 54 | 17-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.85 | +11.11% | 10,443,832 |
24-04-23 | 0.765 | +8.20% | 791,938 |
24-04-22 | 0.707 | -3.55% | 872,297 |
24-04-19 | 0.733 | -4.17% | 443,545 |
24-04-18 | 0.7649 | +0.31% | 172,841 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.94% | 84.11M | |
+25.61% | 660B | |
+23.85% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+12.66% | 219B | |
-9.98% | 196B | |
+6.89% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- HOOK Stock